129 related articles for article (PubMed ID: 29413668)
1. QTc prolongation, increased NT-proBNP and pre-clinical myocardial wall remodeling in excessive alcohol consumers: The SABPA study.
Wentzel A; Malan L; Scheepers JD; Malan NT
Alcohol; 2018 May; 68():1-8. PubMed ID: 29413668
[TBL] [Abstract][Full Text] [Related]
2. Fibrosis and coronary perfusion - a cardiovascular disease risk in an African male cohort: The SABPA study.
Jansen van Vuren E; Malan L; Cockeran M; Scheepers JD; Oosthuizen W; Malan NT
Clin Exp Hypertens; 2016; 38(5):482-8. PubMed ID: 27380493
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes of cardiac troponin and inflammation reflect progressive myocyte stretch and likelihood for hypertension in a Black male cohort: The SABPA study.
Jansen van Vuren E; Malan L; von Känel R; Lammertyn L; Cockeran M; Malan NT
Hypertens Res; 2019 May; 42(5):708-716. PubMed ID: 30626934
[TBL] [Abstract][Full Text] [Related]
4. The defense response and alcohol intake: A coronary artery disease risk? The SABPA Study.
Oosthuizen W; Malan L; Scheepers JD; Cockeran M; Malan NT
Clin Exp Hypertens; 2016; 38(6):526-32. PubMed ID: 27399032
[TBL] [Abstract][Full Text] [Related]
5. Hyperpulsatile pressure, systemic inflammation and cardiac stress are associated with cardiac wall remodeling in an African male cohort: the SABPA study.
van Vuren EJ; Malan L; von Känel R; Cockeran M; Malan NT
Hypertens Res; 2016 Sep; 39(9):648-53. PubMed ID: 27169396
[TBL] [Abstract][Full Text] [Related]
6. NT-proBNP is associated with fibulin-1 in Africans: the SAfrEIC study.
Kruger R; Schutte R; Huisman HW; Argraves WS; Rasmussen LM; Olsen MH; Schutte AE
Atherosclerosis; 2012 May; 222(1):216-21. PubMed ID: 22349089
[TBL] [Abstract][Full Text] [Related]
7. Low grade inflammation and ECG left ventricular hypertrophy in urban African males: The SABPA study.
van der Walt C; Malan L; Uys AS; Malan NT
Heart Lung Circ; 2013 Nov; 22(11):924-9. PubMed ID: 23711691
[TBL] [Abstract][Full Text] [Related]
8. NT-proBNP and metabolic risk factors in a bi-ethnic cohort: the Ambulatory Blood Pressure in African prospective cohort study.
Jujić A; Melander O; Nilsson PM; Malan L; Fedorowski A; Magnusson M
Cardiovasc J Afr; 2020; 31(6):291-297. PubMed ID: 33180090
[TBL] [Abstract][Full Text] [Related]
9. Coping and Cardiac Troponin T - A Risk for Hypertension and Sub-Clinical ECG Left Ventricular Hypertrophy: The SABPA Study.
Myburgh CE; Malan L; Wentzel A; Scheepers JW; Malan NT
Heart Lung Circ; 2019 Jun; 28(6):908-916. PubMed ID: 29895484
[TBL] [Abstract][Full Text] [Related]
10. Facilitated defensive coping, silent ischaemia and ECG left-ventricular hypertrophy: the SABPA study.
Malan L; Hamer M; Schlaich MP; Lambert GW; Harvey BH; Reimann M; Ziemssen T; de Geus EJ; Huisman HW; van Rooyen JM; Schutte R; Schutte AE; Fourie CM; Seedat YK; Malan NT
J Hypertens; 2012 Mar; 30(3):543-50. PubMed ID: 22245987
[TBL] [Abstract][Full Text] [Related]
11. Biological, electrical and echocardiographic indices versus cardiac magnetic resonance imaging in diagnosing left ventricular hypertrophy.
Courand PY; Gaudebout N; Mouly-Bertin C; Thomson V; Fauvel JP; Bricca G; Lantelme P
Hypertens Res; 2014 May; 37(5):444-51. PubMed ID: 24132010
[TBL] [Abstract][Full Text] [Related]
12. N-terminal prohormone B-type natriuretic peptide and cardiovascular function in Africans and Caucasians: the SAfrEIC study.
Kruger R; Schutte R; Huisman HW; Hindersson P; Olsen MH; Schutte AE
Heart Lung Circ; 2012 Feb; 21(2):88-95. PubMed ID: 22119736
[TBL] [Abstract][Full Text] [Related]
13. IGF-1 and NT-proBNP in a black and white population: The SABPA study.
Koegelenberg AS; Smith W; Schutte R; Schutte AE
Eur J Clin Invest; 2016 Sep; 46(9):795-803. PubMed ID: 27455178
[TBL] [Abstract][Full Text] [Related]
14. Retinal Vasculature Reactivity During Flicker Light Provocation, Cardiac Stress and Stroke Risk in Africans: The SABPA Study.
Wentzel A; Malan L; Smith W; von Känel R; Malan NT
Transl Stroke Res; 2019 Oct; 10(5):485-494. PubMed ID: 30414101
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
[TBL] [Abstract][Full Text] [Related]
17. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.
Rich JD; Thenappan T; Freed B; Patel AR; Thisted RA; Childers R; Archer SL
Int J Cardiol; 2013 Aug; 167(3):669-76. PubMed ID: 22459397
[TBL] [Abstract][Full Text] [Related]
18. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
[TBL] [Abstract][Full Text] [Related]
19. Impact of left ventricular hypertrophy on QT prolongation and associated mortality.
Haugaa KH; Bos JM; Borkenhagen EJ; Tarrell RF; Morlan BW; Caraballo PJ; Ackerman MJ
Heart Rhythm; 2014 Nov; 11(11):1957-65. PubMed ID: 24956189
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic accuracy of NT-proBNP compared with electrocardiography in detecting left ventricular hypertrophy of hypertensive origin].
Andrade H; Morillas P; Castillo J; Roldán J; Mateo I; Agudo P; Quiles J; Bertomeu-Martínez V
Rev Esp Cardiol; 2011 Oct; 64(10):939-41. PubMed ID: 21664755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
